Troy Wilson recruits AstraZeneca vet to steer Kura's late-stage pivot
Seven months after Kura Oncology bid farewell with co-founder and chief medical officer Antonio Gualberto, the biotech has found his successor from the ranks of …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.